DrugPatentWatch Database Preview
Profile for Israel Patent: 166964
US Patent Family Members and Approved Drugs for Israel Patent: 166964
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Aug 12, 2023 | Boehringer Ingelheim | JENTADUETO XR | linagliptin; metformin hydrochloride |
➤ Try a Free Trial | Aug 12, 2023 | Boehringer Ingelheim | GLYXAMBI | empagliflozin; linagliptin |
➤ Try a Free Trial | Aug 12, 2023 | Boehringer Ingelheim | JENTADUETO | linagliptin; metformin hydrochloride |
➤ Try a Free Trial | Aug 12, 2023 | Boehringer Ingelheim | TRADJENTA | linagliptin |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |